Kcnt2 Related Disorder Cn236796
A genetic condition involving potassium channel dysfunction, leading to developmental problems and seizures. Treatment aims to control seizures and support development.
Key facts at a glance
- ICD-10
- G40.909
- ICD-11
- 8A00.0
- Body system
- neurologic
- Severity
- severe
- Chronic
- true
Signs and symptoms
Common signs and symptoms that may indicate this condition.
Warning signs - seek immediate care
Severe early-onset epilepsy
Myoclonic seizures
Cortical malformations
Generalized symptoms
(neurologic)Significant symptoms that substantially affect daily functioning.
Frequency: Common at all stages
Developmental regression
(neurologic)Diagnosis and tests
How this condition is diagnosed and what test results mean.
Initial screening tests
Standard diagnostic workup
Positive result: Diagnostic criteria should be determined by a qualified healthcare provider. [Content pending medical review.]
Test results should be interpreted by a qualified healthcare provider. [Content pending medical review.]
Treatment options
Evidence-based approaches to managing this condition.
First-line treatments
Sodium Channel Blocker Therapy
Phenytoin or carbamazepine therapy targeting voltage-gated sodium channels to reduce seizure frequency and improve neurological outcomes. Response rates vary significantly among affected individuals.
Targeted drug therapy with dose adjustment
Active treatment with regular monitoring by a healthcare provider is recommended.
Potassium Channel Activators
Ezogabine increases KCNQ channel activity and may provide targeted therapeutic benefit in KCNT2-related disorders. Emerging evidence supports potential efficacy in channelopathies affecting potassium conductance.
Additional treatment options
Seizure and Developmental Monitoring
Structured monitoring programs including regular EEG studies and standardized developmental assessments to track disease course and treatment response over time.
monitoringIntensive Motor Rehabilitation
Goal-directed physical and occupational therapy addressing motor delays, hypotonia, and coordination difficulties commonly seen in KCNT2-related disorders. May include constraint-induced movement therapy.
physical_therapyNutritional Support Services
Dietetic input for management of feeding difficulties, failure to thrive, or gastrointestinal comorbidities common in severe neurodevelopmental disorders. May include modified textures or supplemental nutrition.
dietaryWhen to seek medical help
Recognize when you need immediate medical attention.
See a doctor within 24 hours
Moderate to severe symptoms that may indicate worsening of this condition. Prompt medical evaluation is recommended.
Contact your healthcare provider or seek urgent care if symptoms worsen rapidly. Go to the emergency department for life-threatening symptoms.
Frequently asked questions
Common questions about this topic.
What is Kcnt2 Related Disorder Cn236796?
Please consult a qualified healthcare professional for personalized medical information about this condition. [Content pending medical review.]
generalMedication Comparisons
Compare medications used to treat Kcnt2 Related Disorder Cn236796. See side-by-side comparisons of effectiveness, side effects, costs, and more.
View Medication ComparisonsThis information is for educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment.
This content is for general informational and educational purposes only and is not a substitute for professional medical advice, diagnosis, or treatment. Always seek the guidance of a qualified healthcare provider with any questions you have about a medical condition, and never disregard professional medical advice or delay seeking it because of something you read here.
If you think you may have a medical emergency, call your local emergency number or go to the nearest emergency department immediately.
Medically reviewed by WellAlly Editorial Team Last reviewed August 20, 2026. · Read our editorial policy